How much does Verzenio cost?

Pricing for Verzenio varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Verzenio need prior authorization?

Verzenio appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Verzenio?

We haven't verified an active copay card or PAP for Verzenio in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Verzenio used to treat?

Verzenio (generic: abemaciclib) is indicated for Cancer, Breast Cancer, Chemotherapy. Click any condition name on this page for more detail.

Does Verzenio have a generic version?

The generic name for Verzenio is abemaciclib. Whether a generic is currently available depends on patent status — check the FDA Orange Book or ask your pharmacist. Generics are often substantially cheaper than brand-name drugs.

Verzenio

Generic: abemaciclib

Data may be stale·Apr 23, 2026

Manufacturer: Eli Lilly
NDC: 0002-6216
RxCUI: 1946830
Route: ORAL
ICD-10 indication: C50.919

Affordability Check

How much will you actually pay for Verzenio?

In 30 seconds, see every legitimate way to afford Verzenio — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Verzenio

What is this medication?

Verzenio, known generically as abemaciclib, is a prescription medication categorized as a kinase inhibitor. It works by blocking specific proteins called cyclin-dependent kinases 4 and 6, which are involved in the growth and division of cancer cells. By inhibiting these proteins, the drug helps slow or stop the progression of hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) breast cancer.

This medication is typically prescribed for adults with advanced or metastatic breast cancer, either as a stand-alone therapy or in combination with endocrine treatments like aromatase inhibitors or fulvestrant. It is also used in certain patients with early-stage breast cancer who have a high risk of the disease returning after surgery. Healthcare providers determine the appropriate dosage and treatment plan based on the specific stage of the cancer and the patient's overall health status.

Copay & patient assistance

Patient Copay Amount: As little as $0 per 28-day supply.
Maximum Annual Benefit Limit: Up to $10,600 per calendar year (limited to 14 fills per year); if the patient is enrolled in a "Maximizer" plan, the limit is reduced to $350 per calendar year.
Core Eligibility Restrictions: Must have commercial insurance coverage for Verzenio; 18 years of age or older; resident of the United States or Puerto Rico; not enrolled in any state or federal government-funded healthcare program (including Medicare, Medicaid, or TRICARE); prohibited for patients using an Alternative Funding Program (AFP); requires a valid HIPAA authorization.
RxBIN, PCN, and Group numbers: Not Publicly Available.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for abemaciclib.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Verzenio →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for abemaciclib →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Verzenio appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

28%

1,551 of 5,499 plans

Most common tier

Tier 5

On 80% of covering formularies

Prior authorization required

99%

of covering formularies

Tier	Formularies on this tier	Share
Tier 1 (preferred generic)	43	17%
Tier 2 (generic)	2	1%
Tier 4 (non-preferred brand)	7	3%
Tier 5 (specialty)	204	80%

Step therapy: 0% of formularies

Quantity limits: 85% of formularies

Coverage breadth: 256 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.